| Name | Role | Date | Shares | Price | Value | 
|---|---|---|---|---|---|
| Michael S. Cuffe | EVP and Chief Clinical Officer | 2025-09-08 | 3,836 | $418.84 | $1.61MSell | 
| Michael S. Cuffe | EVP and Chief Clinical Officer | 2025-09-04 | 10,920 | $173.12 | $1.89MBuy | 
| Michael S. Cuffe | EVP and Chief Clinical Officer | 2025-09-04 | 7,084 | $411.59 | $2.92MSell | 
| Jon M. Foster | EVP and COO | 2025-05-13 | 15,925 | $367.20 | $5.85MBuy | 
| Jon M. Foster | EVP and COO | 2025-05-13 | 15,925 | $367.20 | $5.85MSell | 
| Jon M. Foster | EVP and COO | 2025-05-13 | 15,698 | $369.33 | $5.80MSell | 
| Mike A. Marks | EVP and CFO | 2025-05-07 | 285 | $356.84 | $101.70kBuy | 
| Mike A. Marks | EVP and CFO | 2025-05-07 | 285 | $356.84 | $101.70kSell | 
| Mike A. Marks | EVP and CFO | 2025-05-06 | 288 | $353.58 | $101.83kBuy | 
| Mike A. Marks | EVP and CFO | 2025-05-06 | 288 | $353.58 | $101.83kSell | 
| Name | Hold | Shares | Value | Type | 
|---|---|---|---|---|
| Patricia F. Elcan | 86.02% | 201,280,147 | $94.28B | Insider | 
| Thomas F. Frist Iii | 81.94% | 191,739,942 | $89.81B | Insider | 
| William R. Frist | 78.48% | 183,636,539 | $86.02B | Insider | 
| Thomas F. Frist Jr. | 64.36% | 150,592,723 | $70.54B | Insider | 
| Patricia C. Frist | 44.69% | 104,563,679 | $48.98B | Insider | 
| Bank Of America Corp | 38.78% | 90,740,672 | $42.50B | Insider | 
| Holding Hercules Ii | 29.45% | 68,912,077 | $32.28B | Insider | 
| Michael W. Michelson | 20.42% | 47,792,629 | $22.39B | Insider | 
| Kkr Pei Investments LP | 19.44% | 45,498,364 | $21.31B | Insider | 
| John Connaughton | 12.82% | 30,003,156 | $14.05B | Insider |